Daito PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Daito PharmaceuticalLtd has a total shareholder equity of ¥52.1B and total debt of ¥12.1B, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are ¥81.9B and ¥29.8B respectively. Daito PharmaceuticalLtd's EBIT is ¥3.7B making its interest coverage ratio -406.9. It has cash and short-term investments of ¥4.7B.
Key information
23.3%
Debt to equity ratio
JP¥12.14b
Debt
| Interest coverage ratio | -406.9x |
| Cash | JP¥4.69b |
| Equity | JP¥52.08b |
| Total liabilities | JP¥29.85b |
| Total assets | JP¥81.93b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4577's short term assets (¥45.8B) exceed its short term liabilities (¥18.8B).
Long Term Liabilities: 4577's short term assets (¥45.8B) exceed its long term liabilities (¥11.1B).
Debt to Equity History and Analysis
Debt Level: 4577's net debt to equity ratio (14.3%) is considered satisfactory.
Reducing Debt: 4577's debt to equity ratio has increased from 14% to 23.3% over the past 5 years.
Debt Coverage: 4577's debt is well covered by operating cash flow (42.7%).
Interest Coverage: 4577 earns more interest than it pays, so coverage of interest payments is not a concern.